The Outsourcing Selection Process

Rob Wright, chief editor of Life Science Leader, conducted an executive virtual roundtable with Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy (view full video here). In this component, Contag and Lockert get into the CRO and CMO selection process, sharing an anecdote of reverse engineering from a future launch of what all needs to happen and why. For more information on Contag’s approach to outsourcing, be sure to read, “A Small Biopharma’s View Of Working With CROs,” published in the July 2020 CRO Leadership Awards special supplement.